BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31816127)

  • 1. Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil.
    Johnson LR; Stern JA
    J Vet Intern Med; 2020 Jan; 34(1):65-73. PubMed ID: 31816127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.
    Toom ML; Dobak TP; Broens EM; Valtolina C
    Acta Vet Scand; 2016 Jul; 58(1):46. PubMed ID: 27388158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs.
    Bach JF; Rozanski EA; MacGregor J; Betkowski JM; Rush JE
    J Vet Intern Med; 2006; 20(5):1132-5. PubMed ID: 17063705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study.
    Jaffey JA; Leach SB; Kong LR; Wiggen KE; Bender SB; Reinero CR
    J Vet Cardiol; 2019 Aug; 24():7-19. PubMed ID: 31405557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of pulmonary hypertension assessed using the pulmonary vein-to-right pulmonary artery ratio and its association with survival in West Highland white terriers with canine idiopathic pulmonary fibrosis.
    Roels E; Fastrès A; Merveille AC; Bolen G; Teske E; Clercx C; Mc Entee K
    BMC Vet Res; 2021 Apr; 17(1):171. PubMed ID: 33892687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014.
    Kellihan HB; Waller KR; Pinkos A; Steinberg H; Bates ML
    J Vet Cardiol; 2015 Sep; 17(3):182-91. PubMed ID: 26293206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension.
    Kellum HB; Stepien RL
    J Vet Intern Med; 2007; 21(6):1258-64. PubMed ID: 18196735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous tricuspid valve chordal rupture in a dog with severe, irreversible pulmonary hypertension caused by Angiostrongylus vasorum infection.
    Szatmári V
    BMC Vet Res; 2020 Aug; 16(1):311. PubMed ID: 32847583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunct ambrisentan therapy had clinical benefits in 5 dogs with sildenafil-refractory pulmonary hypertension.
    Goya S; Yoshida T; Sennba S; Uchide T; Tanaka R
    Can Vet J; 2022 May; 63(5):497-503. PubMed ID: 35502246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of long-term sildenafil therapy in a young dog with pulmonary hypertension.
    Toyoshima Y; Kanemoto I; Arai S; Toyoshima H
    J Vet Med Sci; 2007 Oct; 69(10):1073-5. PubMed ID: 17984597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of sildenafil on pulmonary haemodynamics in a canine model of chronic embolic pulmonary hypertension.
    Akabane R; Sakatani A; Ogawa M; Nagakawa M; Miyakawa H; Miyagawa Y; Takemura N
    Res Vet Sci; 2020 Dec; 133():106-110. PubMed ID: 32961474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi.
    Morita T; Nakamura K; Osuga T; Kobayashi A; Ichii O; Yabuki A; Takiguchi M
    J Vet Med Sci; 2018 Jun; 80(6):939-944. PubMed ID: 29681557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension.
    Ueda Y; Johnson LR; Ontiveros ES; Visser LC; Gunther-Harrington CT; Stern JA
    Sci Rep; 2019 May; 9(1):6899. PubMed ID: 31053768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
    Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs.
    Brown AJ; Davison E; Sleeper MM
    J Vet Intern Med; 2010; 24(4):850-4. PubMed ID: 20412435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
    Sastry BK; Narasimhan C; Reddy NK; Raju BS
    J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: Clinical features, diagnostic testing and survival.
    Jaffey JA; Wiggen K; Leach SB; Masseau I; Girens RE; Reinero CR
    Vet J; 2019 Sep; 251():105347. PubMed ID: 31492386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graded balloon atrial septostomy for palliation of congenital pulmonary hypertension in a dog: A case report.
    Allen J; Peterson N; Barrett K; Llamas A
    J Vet Intern Med; 2020 Jan; 34(1):283-288. PubMed ID: 31769097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia.
    Herbert S; Tulloh R
    Early Hum Dev; 2016 Nov; 102():21-24. PubMed ID: 27665322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.